Laboratory Of Stock Current Valuation
| LH Stock | USD 201.32 1.07 0.53% |
Valuation analysis of Laboratory helps investors to measure Laboratory's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The Laboratory's current Enterprise Value is estimated to increase to about 8.7 B, while Enterprise Value Over EBITDA is projected to decrease to 10.38. Fundamental drivers impacting Laboratory's valuation include:
Price Book 2.1977 | Enterprise Value 22.9 B | Enterprise Value Ebitda 16.8856 | Price Sales 1.4231 | Forward PE 13.8504 |
Fairly Valued
Today
Please note that Laboratory's price fluctuation is very steady at this time. Calculation of the real value of Laboratory is based on 3 months time horizon. Increasing Laboratory's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Laboratory of is useful when determining the fair value of the Laboratory stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Laboratory. Since Laboratory is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Laboratory Stock. However, Laboratory's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 201.32 | Real 201.56 | Target 244.08 | Hype 201.53 | Naive 203.51 |
The real value of Laboratory Stock, also known as its intrinsic value, is the underlying worth of Laboratory Company, which is reflected in its stock price. It is based on Laboratory's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Laboratory's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Laboratory's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Laboratory of helps investors to forecast how Laboratory stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Laboratory more accurately as focusing exclusively on Laboratory's fundamentals will not take into account other important factors: Laboratory of Company Current Valuation Analysis
Laboratory's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Laboratory Current Valuation | 22.93 B |
Most of Laboratory's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratory of is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Laboratory Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Laboratory is extremely important. It helps to project a fair market value of Laboratory Stock properly, considering its historical fundamentals such as Current Valuation. Since Laboratory's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Laboratory's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Laboratory's interrelated accounts and indicators.
Click cells to compare fundamentals
Laboratory Current Valuation Historical Pattern
Today, most investors in Laboratory Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Laboratory's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Laboratory current valuation as a starting point in their analysis.
Laboratory Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Laboratory of has a Current Valuation of 22.93 B. This is 59.66% higher than that of the Health Care Providers & Services sector and 194.14% higher than that of the Health Care industry. The current valuation for all United States stocks is 37.95% lower than that of the firm.
Laboratory Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratory's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratory could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics of similar companies.Laboratory is currently under evaluation in current valuation category among related companies.
Laboratory ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Laboratory Fundamentals
| Return On Equity | 0.0437 | ||||
| Return On Asset | 0.0376 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 22.93 B | ||||
| Shares Outstanding | 84.29 M | ||||
| Shares Owned By Insiders | 0.35 % | ||||
| Shares Owned By Institutions | 98.99 % | ||||
| Number Of Shares Shorted | 2.26 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.20 X | ||||
| Price To Sales | 1.42 X | ||||
| Revenue | 12.16 B | ||||
| Gross Profit | 4.39 B | ||||
| EBITDA | 1.7 B | ||||
| Net Income | 379.2 M | ||||
| Cash And Equivalents | 430 M | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 5.95 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 94.42 X | ||||
| Cash Flow From Operations | 1.33 B | ||||
| Short Ratio | 3.11 X | ||||
| Earnings Per Share | 4.67 X | ||||
| Price To Earnings To Growth | 0.48 X | ||||
| Target Price | 241.53 | ||||
| Number Of Employees | 67 K | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 16.96 B | ||||
| Total Asset | 16.73 B | ||||
| Retained Earnings | 7.89 B | ||||
| Working Capital | 540.2 M | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 16.73 B | ||||
| Last Dividend Paid | 2.88 |
About Laboratory Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Laboratory Investors Sentiment
The influence of Laboratory's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Laboratory. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Laboratory's public news can be used to forecast risks associated with an investment in Laboratory. The trend in average sentiment can be used to explain how an investor holding Laboratory can time the market purely based on public headlines and social activities around Laboratory of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Laboratory's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Laboratory's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Laboratory's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Laboratory.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Laboratory in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Laboratory's short interest history, or implied volatility extrapolated from Laboratory options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Laboratory Piotroski F Score and Laboratory Altman Z Score analysis. Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.123 | Dividend Share 2.88 | Earnings Share 4.67 | Revenue Per Share 142.986 | Quarterly Revenue Growth 0.046 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.